What causes Alzheimer’s?
Unexplainable
00:00
Alzheimer's Drug Dilemma: The Aducanumab Controversy
This chapter delves into the complexities of Alzheimer's drug development, specifically focusing on the amyloid hypothesis and the contentious approval of aducanumab by the FDA. It examines the ethical implications and mixed community reactions to a drug that may offer hope yet poses significant questions about efficacy and regulatory practices.
Transcript
Play full episode
